Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 3/2018

09.11.2017 | Original Article

Benefit of Surgical Resection of the Primary Tumor in Patients Undergoing Chemotherapy for Stage IV Colorectal Cancer with Unresected Metastasis

verfasst von: Sean Maroney, Carlos Chavez de Paz, Mark E. Reeves, Carlos Garberoglio, Elizabeth Raskin, Maheswari Senthil, Jukes P. Namm, Naveenraj Solomon

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Resection of the primary tumor in patients with unresected metastatic colorectal cancer is controversial, and often performed only for palliation of symptoms. Our goal was to determine if resection of the primary tumor in this patient population is associated with improved survival.

Methods

This is a retrospective cohort study of the National Cancer Data Base from 2004 to 2012. The study population included all patients with synchronous metastatic colorectal adenocarcinoma who were treated with systemic chemotherapy. The study groups were patients who underwent definitive surgery for the primary tumor and those who did not. Patients were excluded if they had surgical intervention on the sites of metastasis or pathology other than adenocarcinoma. Primary outcome was overall survival.

Results

Of the 65,543 patients with unresected stage IV colorectal adenocarcinoma undergoing chemotherapy, 55% underwent surgical resection of the primary site. Patients who underwent surgical resection of the primary tumor had improved median survival compared to patients treated with chemotherapy alone (22 vs 13 months, p < .0001). The surgical survival benefit was present for patients who were treated with either multi-agent or single-agent chemotherapy (23 vs 14 months, p < 0.001; 19 vs 9 months, p < 0.001). Surgical resection of the primary tumor was also associated with improved survival when using multivariate analysis with propensity score matching (OR = 0.863; 95% CI [0.805–.924]; HR = 0.914; 95% CI [0.888–0.942]).

Conclusions

Our results show that in patients with synchronous unresected stage IV colorectal adenocarcinoma undergoing single- or multi-agent chemotherapy, after adjusting for confounding variables, definitive resection of the primary site was associated with improved overall survival. Large randomized controlled trials are needed to determine if there is a causal relationship between surgery and increased overall survival in this patient population.
Literatur
1.
Zurück zum Zitat Faron M, Pignon JP, Malka D et al. Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials. Eur J Cancer 2015;51:166–176.CrossRefPubMed Faron M, Pignon JP, Malka D et al. Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials. Eur J Cancer 2015;51:166–176.CrossRefPubMed
2.
Zurück zum Zitat Miller KD, Siegel RL, Lin CC et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 2016;66:271–289.CrossRefPubMed Miller KD, Siegel RL, Lin CC et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 2016;66:271–289.CrossRefPubMed
3.
Zurück zum Zitat Chun YS, Vauthey JN. Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol 2007;33 Suppl 2:S52–58.CrossRefPubMed Chun YS, Vauthey JN. Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol 2007;33 Suppl 2:S52–58.CrossRefPubMed
4.
5.
Zurück zum Zitat Matsumoto T, Hasegawa S, Matsumoto S et al. Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor. Dis Colon rectum 2014;57:679–686. Matsumoto T, Hasegawa S, Matsumoto S et al. Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor. Dis Colon rectum 2014;57:679–686.
6.
Zurück zum Zitat Benson AB, 3rd, Venook AP, Cederquist L et al. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017;15:370–398.CrossRefPubMed Benson AB, 3rd, Venook AP, Cederquist L et al. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017;15:370–398.CrossRefPubMed
7.
Zurück zum Zitat Massarweh NN, Li LT, Sansgiry S et al. Primary tumor resection and multimodality treatment for patients with metastatic colon cancer. Ann Surg Oncol 2016;23:1815–1823.CrossRefPubMed Massarweh NN, Li LT, Sansgiry S et al. Primary tumor resection and multimodality treatment for patients with metastatic colon cancer. Ann Surg Oncol 2016;23:1815–1823.CrossRefPubMed
8.
Zurück zum Zitat Tarantino I, Warschkow R, Worni M et al. Prognostic relevance of palliative primary tumor removal in 37,793 metastatic colorectal cancer patients: a population-based, propensity score-adjusted trend analysis. Ann Surg 2015;262:112–120.CrossRefPubMed Tarantino I, Warschkow R, Worni M et al. Prognostic relevance of palliative primary tumor removal in 37,793 metastatic colorectal cancer patients: a population-based, propensity score-adjusted trend analysis. Ann Surg 2015;262:112–120.CrossRefPubMed
9.
Zurück zum Zitat Mik M, Dziki L, Galbfach P et al. Resection of the primary tumour or other palliative procedures in incurable stage IV colorectal cancer patients? Colorectal Dis 2010;12:e61–67.CrossRefPubMed Mik M, Dziki L, Galbfach P et al. Resection of the primary tumour or other palliative procedures in incurable stage IV colorectal cancer patients? Colorectal Dis 2010;12:e61–67.CrossRefPubMed
10.
Zurück zum Zitat Gulack BC, Nussbaum DP, Keenan JE et al. Surgical resection of the primary tumor in stage iv colorectal cancer without metastasectomy is associated with improved overall survival compared with chemotherapy/radiation therapy alone. Dis Colon rectum 2016;59:299–305. Gulack BC, Nussbaum DP, Keenan JE et al. Surgical resection of the primary tumor in stage iv colorectal cancer without metastasectomy is associated with improved overall survival compared with chemotherapy/radiation therapy alone. Dis Colon rectum 2016;59:299–305.
11.
Zurück zum Zitat Ruo L, Gougoutas C, Paty PB et al. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 2003;196:722–728.CrossRefPubMed Ruo L, Gougoutas C, Paty PB et al. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 2003;196:722–728.CrossRefPubMed
12.
Zurück zum Zitat Ishihara S, Hayama T, Yamada H et al. Prognostic impact of primary tumor resection and lymph node dissection in stage IV colorectal cancer with unresectable metastasis: a propensity score analysis in a multicenter retrospective study. Ann Surg Oncol 2014;21:2949–2955.CrossRefPubMed Ishihara S, Hayama T, Yamada H et al. Prognostic impact of primary tumor resection and lymph node dissection in stage IV colorectal cancer with unresectable metastasis: a propensity score analysis in a multicenter retrospective study. Ann Surg Oncol 2014;21:2949–2955.CrossRefPubMed
13.
Zurück zum Zitat Cirocchi R, Trastulli S, Abraha I et al. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Syst Rev 2012; CD008997. Cirocchi R, Trastulli S, Abraha I et al. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Syst Rev 2012; CD008997.
14.
Zurück zum Zitat Yun JA, Huh JW, Park YA et al. The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer. Dis Colon rectum 2014;57:1049–1058. Yun JA, Huh JW, Park YA et al. The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer. Dis Colon rectum 2014;57:1049–1058.
15.
Zurück zum Zitat Sundararajan V, Henderson T, Perry C et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004;57:1288–1294.CrossRefPubMed Sundararajan V, Henderson T, Perry C et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004;57:1288–1294.CrossRefPubMed
16.
Zurück zum Zitat Legendre H, Vanhuyse F, Caroli-Bosc FX, Pector JC. Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction. Eur J Surg Oncol 2001;27:364–367.CrossRefPubMed Legendre H, Vanhuyse F, Caroli-Bosc FX, Pector JC. Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction. Eur J Surg Oncol 2001;27:364–367.CrossRefPubMed
17.
Zurück zum Zitat Amelung FJ, Mulder CL, Broeders IA et al. Efficacy of loop colostomy construction for acute left-sided colonic obstructions: a cohort analysis. Int J Colorectal Dis 2017;32:383–390.CrossRefPubMed Amelung FJ, Mulder CL, Broeders IA et al. Efficacy of loop colostomy construction for acute left-sided colonic obstructions: a cohort analysis. Int J Colorectal Dis 2017;32:383–390.CrossRefPubMed
19.
Zurück zum Zitat Ghiringhelli F, Bichard D, Limat S et al. Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection. Ann Surg Oncol 2014;21:1632–1640.CrossRefPubMedPubMedCentral Ghiringhelli F, Bichard D, Limat S et al. Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection. Ann Surg Oncol 2014;21:1632–1640.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Abajo A, Bitarte N, Zarate R et al. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array. World J Gastroenterol 2012;18:637–645.CrossRefPubMedPubMedCentral Abajo A, Bitarte N, Zarate R et al. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array. World J Gastroenterol 2012;18:637–645.CrossRefPubMedPubMedCentral
21.
22.
Zurück zum Zitat Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 2005;12:637–645.CrossRefPubMed Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 2005;12:637–645.CrossRefPubMed
23.
Zurück zum Zitat Cotte E, Villeneuve L, Passot G et al. GRECCAR 8: impact on survival of the primary tumor resection in rectal cancer with unresectable synchronous metastasis: a randomized multicentre study. BMC Cancer 2015;15:47.CrossRefPubMedPubMedCentral Cotte E, Villeneuve L, Passot G et al. GRECCAR 8: impact on survival of the primary tumor resection in rectal cancer with unresectable synchronous metastasis: a randomized multicentre study. BMC Cancer 2015;15:47.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Rahbari NN, Lordick F, Fink C et al. Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS—a randomised controlled multicentre trial (ISRCTN30964555). BMC Cancer 2012;12:142.CrossRefPubMedPubMedCentral Rahbari NN, Lordick F, Fink C et al. Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS—a randomised controlled multicentre trial (ISRCTN30964555). BMC Cancer 2012;12:142.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat ‘t Lam-Boer J, Mol L, Verhoef C et al. The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer—a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG). BMC Cancer 2014;14:741.CrossRef ‘t Lam-Boer J, Mol L, Verhoef C et al. The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer—a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG). BMC Cancer 2014;14:741.CrossRef
Metadaten
Titel
Benefit of Surgical Resection of the Primary Tumor in Patients Undergoing Chemotherapy for Stage IV Colorectal Cancer with Unresected Metastasis
verfasst von
Sean Maroney
Carlos Chavez de Paz
Mark E. Reeves
Carlos Garberoglio
Elizabeth Raskin
Maheswari Senthil
Jukes P. Namm
Naveenraj Solomon
Publikationsdatum
09.11.2017
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 3/2018
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-017-3617-5

Weitere Artikel der Ausgabe 3/2018

Journal of Gastrointestinal Surgery 3/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.